A VALIDATED REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS DETERMINATION OF FIVE ANTIEPILEPTIC DRUGS USED IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME IN THEIR PHARMACEUTICAL DOSAGE FORMS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i5.24143Keywords:
Rufinamide, Lamotrigine, Clonazepam, Valproic acid, Diazepam, High-performance liquid chromatography, Dosage formAbstract
 Objective: Lennox–Gastaut syndrome (LGS) is mainly treated with antiepileptic drugs (AEDs) but using one AED is not sufficient to relieve all or even most patients. A combination of agents is usually preferred. In the current study, an isocratic, selective, sensitive, precise, and accurate reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed for the simultaneous determination of rufinamide (RUF), lamotrigine (LAM), clonazepam (CLO), valproic acid (VAL), and diazepam (DIA) which are commonly used in the management of LGS in their dosage forms using lacosamide as internal standard.
Methods: The method depends on using RESTEK C18 column (5 μm, 250 mm × 4.6 mm) and a mobile phase composed of acetonitrile:water (55: 45, v/v), pH = 3.3 adjusted with phosphoric acid. The method was conducted in an isocratic mode with a flow rate of 1ml/min and ultraviolet detection at 210 nm.
Results: The linearity range was 2–40 μg/ml for RUF and DIA, 0.5–40 μg/ml for LAM and CLO, and 36–180 μg/ml for VAL.
Conclusion: Statistical analysis revealed no significant difference between the results obtained and the official or reported ones for each cited drug. The method is simple to be easily implemented in quality control studies of the mentioned drugs in their pharmaceutical preparations.
Downloads
References
Sharma S, Jain P, Gulati S, Sankhyan N, Agarwala A. Use of the modified atkins diet in lennox gastaut syndrome. J Child Neurol 2015;30:576-9.
Cramer JA, Sapin C, François C. Indirect comparison of clobazam and other therapies for lennox–gastaut syndrome. Acta Neurol Scand 2013;128:91-9.
Crumrine PK. Management of seizures in lennox-gastaut syndrome. Paediatr Drugs 2011;13:107-18.
Hancock EC, Cross HJ. Treatment of lennox-gastaut syndrome. Cochrane Database of Syst Rev 2009;3:CD003277.
Lemmon ME, Kossoff EH. New treatment options for lennox-gastaut syndrome. Curr Treat Options Neurol 2013;15:519-28.
Culy CR, Goa KL. Lamotrigine. A review of its use in childhood epilepsy. Paediatr Drugs 2000;2:299-330.
Montouris GD, Wheless JW, Glauser TA. The efficacy and tolerability of pharmacologic treatment options for lennox-gastaut syndrome. Epilepsia 2014;55 Suppl 4:10-20.
van Rijckevorsel K. Treatment of lennox-gastaut syndrome: Overview and recent findings. Neuropsychiatr Dis Treat 2008;4:1001-19.
Stafstrom CE. Update on the management of lennox-gastaut syndrome with a focus on rufinamide. Neuropsychiatr Dis Treat 2009;5:547-51.
Gresham J, Eiland LS, Chung AM. Treating lennox–gastaut syndrome in epileptic pediatric patients with third-generation rufinamide. Neuropsychiatr Dis Treat 2010;6:639-45.
Vijayakumar A, Pandian BG, Emilda MV, Mohan A. Study on prevalence of depression and adverse drug reactions among South Indian epileptic patients. Asian J Pharm Clin Res 2015;8:73-6.
Upadhyay J, Upadhyay G, Rana AJ. A prospective study on prevalence of epilepsy disorders and drug utilization pattern. Asian J Pharm Clin Res 2017;10:136-9.
Alsamman A, Othman M. Preparation and in vitro evaluation of fast release diazepam suppositories for febrile seizures. Asian J Pharm Clin Res 2017;10:224-30.
Sarma P, Bhattacharyya A. Models of epilepsy used in antiepileptic drug discovery: A review. Int J Pharm Pharm Sci 2014;6:1-7.
Pasha I, Kamate M, Suresh DK. Effect of lacosamide on behaviour of children with refractory partial epilepsy. Int J Pharm Pharm Sci 2014;6:119-22.
Sindhu B, Patnaik A, Subrahmanyam KV, Pattnaik P. Validated HPLC technique for determination of drug rufinamide: Applications to stability studies. Int J Innov Pharm Sci Res 2014;2:2691-9.
Patel A, Suhagia DB, Patwari A. Development and validation of stability indicating HPLC method for estimation of rufinamide in bulk and its pharmaceutical dosage form. World J Pharm Res 2014;3:1798-810.
Rajpura P. Analytical method development and validation for assay of rufinamide drug. Management 2013;1:191-203.
Kumar BS, Annapurna MM, Pavani S. Development and validation of a stability indicating RP-HPLC method for the determination of rufinamide. J Pharm Anal 2013;3:66-70.
Yanamadala G, Sravya J. Development and validation of a stability indicating RP-HPLC method for quantification of lamotrigine in bulk and pharmaceutical dosage form. World J Pharm Pharm Sci 2014;3:1502-15.
Reddy T, Ramu G, Babu AB, Rambabu C. Development and validation of HLPC method for the estimation of lamotrigine in bulk and pharmaceutical formulations. J Chem 2012;2013. Article ID: 846170, 4.
Patel A, Kataria M. RP-HPLC method development and validation of lamotrigine in tablet dosage form. Int J Adv Res Pharm BioSci 2012;1:95-102.
Kumar DA, Kumar CV, Seetharamaiah P, Rao JS. Estimation of lamotrigine by RP-HPLC method. J Chem 2010;7:S203-S8.
Patil PM, Wankhede SB, Chaudhari PD. A validated stability–indicating HPLC method estimation of clonazepam in the bulk drug and pharmaceutical dosage form. Pharm Anal Acta 2015;6:332.
Lazar M, Mouzdahi A, Zahouily M. Development and validation of a RP-HPLC method for the determination of clonazepam and related impurities in a pharmaceutical formulation. Asian J Res Biol Pharm Sci 2013;1:9-18.
Uma MK, Lakshmana RP, Balamurali KK, Rambabu C. New validated Rp-Hplc method for the estimation of diazepam in dosage forms. Indo Am J Pharm Res 2014;4:4054-9.
Sruthi A, Tejaswi P, Thanuja N, Kumar DS, Sagar PV. Simple RP-HPLC method for estimation of diazepam in tablet dosage form. J Pharm Res 2013;6:140-4.
Lazar M, Mouzdahir A, Zahouily M. Method development and validation of diazepam in tablet dosage form by HPLC. Asian J Pharm Anal Med Chem 2013;1:140.
Thakkar R, Saravaia H, Ambasana M, Patel M, Shah A. An isocratic method for quantification of valproic acid and its related impurities using ion pair reagent by ultraperformance liquid chromatography. ISRN Chromatogr 2012;2012. Article ID: 836132, 5.
Karde M, Pawar H, Geevarghese R, Khatri J. Development and validation of RP-HPLC method for estimation of valproic acid in dissolution study of its formulation. Int J Pharm Pharm Sci 2012;4 Suppl 5:201-6.
Gupta RK, Kumar S, Singh UK, Iqbal K, Sethia S. Reverse phase high performance liquid chromatographic method for the estimation of valproic acid in bulk drug and soft gelatin capsules. Pharm Chem 2010;2:22-7.
Gupta R, Singh U, Kumar S, Moothan B. Estimation of sodium valproate in tablet dosage form by RP-HPLC without prior derivatization: Application to dissolution studies. Int J Pharm Sci Drug Res 2009;1:103-6.
(ICH) Guidelines Q2 (R1). Validation of Analytical Procedures: Text and Methodology; 2005.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
